The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness

BACKGROUND: Previous reports indicate that treating patients with lupus (SLE) at or close to the time of diagnosis successfully without using any, or minimal, corticosteroids by using B-cell depletion (BCD) is possible in the short-term. It is not however known whether using BCD is as effective or r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gracia-Tello, Borja, Ezeonyeji, Amara, Isenberg, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Clinical Trials and Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294023/
https://www.ncbi.nlm.nih.gov/pubmed/28243455
http://dx.doi.org/10.1136/lupus-2016-000182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294023/
https://www.ncbi.nlm.nih.gov/pubmed/28243455
http://dx.doi.org/10.1136/lupus-2016-000182

Ejemplares similares